PDE5 inhibitors and satisfaction of patients with erectile dysfunction

被引：1
|
作者：
Cour, F. [1 ]
机构：
[1] Hop La Pitie Salpetriere, Serv Urol, F-75651 Paris 13, France
来源：
PROGRES EN UROLOGIE | 2008年 / 18卷 / 08期
关键词：
D O I：
10.1016/j.purol.2008.04.021
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：542 / 542
页数：1
相关论文
共 50 条
  • [21] The impact of the use of PDE5 inhibitors for erectile dysfunction on the lives of Australian men
    H Matic
    M P McCabe
    International Journal of Impotence Research, 2007, 19 : 418 - 423
  • [22] Mechanisms of action of PDE5 inhibition in erectile dysfunction
    Corbin, JD
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2004, 16 (Suppl 1) : S4 - S7
  • [23] Timing of sexual intercourse in erectile dysfunction (ED) patients treated with the three available PDE5 inhibitors
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 140 - 140
  • [24] Mechanisms of action of PDE5 inhibition in erectile dysfunction
    J D Corbin
    International Journal of Impotence Research, 2004, 16 : S4 - S7
  • [25] Phosphodiesterase Type 5 (PDE5) Inhibitors in Erectile Dysfunction: The Proper Drug for the Proper Patient
    Corona, Giovanni
    Mondaini, Nicola
    Ungar, Andrea
    Razzoli, Elisa
    Rossi, Andrea
    Fusco, Ferdinando
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 (12): : 3418 - 3432
  • [26] Pyrroloquinolone PDE5 inhibitors with improved pharmaceutical profiles for clinical studies on erectile dysfunction
    Jiang, WQ
    Guan, JH
    Macielag, MJ
    Zhang, SY
    Qiu, YH
    Kraft, P
    Bhattacharjee, S
    John, TM
    Haynes-Johnson, D
    Lundeen, S
    Sui, ZH
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 2126 - 2133
  • [27] Furoyl and benzofuroyl pyrroloquinolones as potent and selective PDE5 inhibitors for treatment of erectile dysfunction
    Jiang, WQ
    Sui, ZH
    Macielag, MJ
    Walsh, SP
    Fiordeliso, JJ
    Lanter, JC
    Guan, JH
    Qiu, YH
    Kraft, P
    Bhattacharjee, S
    Craig, E
    Haynes-Johnson, D
    John, TM
    Clancy, J
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (03) : 441 - 444
  • [28] Current safety and tolerability issues in men with erectile dysfunction receiving PDE5 inhibitors
    Hellstrom, W. J. G.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (09) : 1547 - 1554
  • [29] Combining testosterone and PDE5 inhibitors in erectile dysfunction: Basic rationale and clinical evidences
    Greco, Emanuela A.
    Spera, Giovanni
    Aversa, Antonio
    EUROPEAN UROLOGY, 2006, 50 (05) : 940 - 947
  • [30] Continuous use of PDE5 inhibitors in the treatment of erectile dysfunction: New insights and opportunities
    Maria Puigvert, Ana
    Prieto, Rafael
    Garcia, Ferran
    REVISTA INTERNACIONAL DE ANDROLOGIA, 2018, 16 (01): : 28 - 33
12345